comparemela.com
  1. Home
  2. Live Updates
  3. Npm1 Mutant Acute Myeloid Leukemia - Breaking News

Latest Breaking News On - Npm1 mutant acute myeloid leukemia - Page 1 : comparemela.com

FDA Grants Breakthrough Therapy Designation to Ziftomenib in NPM1-Mutant AML

The FDA has granted breakthrough therapy designation to ziftomenib for the treatment of NPM1-mutant acute myeloid leukemia.

Germany
Troy-wilson
Kura-oncology
Ziftomenib
Npm1-mutant-acute-myeloid-leukemia

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.